5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Cell-penetrating TAT peptide in drug delivery systems: proteolytic stability requirements.

      Drug delivery

      Animals, Antibiotics, Antineoplastic, administration & dosage, pharmacology, Cell Line, Tumor, Cell-Penetrating Peptides, chemistry, Chromatography, High Pressure Liquid, Dose-Response Relationship, Drug, Doxorubicin, Drug Carriers, Drug Delivery Systems, HeLa Cells, Humans, Melanoma, Experimental, drug therapy, pathology, Mice, Neoplasms, Phosphatidylethanolamines, Polyethylene Glycols, Protein Stability, Trypsin, metabolism, tat Gene Products, Human Immunodeficiency Virus

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The stability and activity of the HIV cell-penetrating TAT peptide (TATp) on the surface of TATp-modified micelles and liposomes in relation to its proteolytic cleavage was investigated. TATp moieties were attached to the surface of these nanocarriers using TATp modified with a conjugate of phosphatidyl ethanolamine with a 'short' PEG (PEG-PE). Following pre-incubation with trypsin, elastase, or collagenase, the proteolytic stability of TATp on the surface of these modified carriers was studied by HPLC with fluorescence detection using fluorenylmethyl chloroformate (FMOC) labeling. All tested enzymes produced a dose-dependent cleavage of TATp as shown by the presence of TATp Arg-Arg fragments. Inhibition of TATp cleavage occurred when these TATp-micelles were modified by the addition of longer PEG-PE blocks, indicating an effective shielding of TATp from proteolysis by these blocks. TATp-modified carriers were also tested for their ability to accumulate in EL-4, HeLa, and B16-F10 cells. Trypsin treatment of TATp-modified liposomes and micelles resulted in decreased uptake and cell interaction, as measured by fluorescence microscopy and fluorescence-activated cell sorting techniques. Furthermore, a decrease in the cytotoxicity of TATp-modified liposomes loaded with doxorubicin (Doxil) was observed following trypsin treatment. In conclusion, steric shielding of TATp is essential to ensure its in vivo therapeutic function.

          Related collections

          Author and article information

          Journal
          21438724
          3482480
          10.3109/10717544.2011.567310

          Comments

          Comment on this article